Development System
FAS_site_01 | SCGE Toolkit
Database of study and experiment data generated by the Somatic Cell Genome Editing Consortium
    
    
    
    
    
        
        
        
        
            
                
                    
                        
                        
                        
                        
                        
                        
                            
                        
                    
                        
                        
                            
                            
                            
                        
    
        | 
        
            
            | A novel human T cell platform to define biological adverse effects of genome editing |  | FAS_site_01 |  
                | Calculated editing efficiency by targeted amplicon deep sequencing |  
                |  |  
                | Editing Efficiency |  | 15000000481 |  | 
 |  | SpCas9 |  | P3 Nucleofection Kit |  | Commercial Reagent |  | FAS_site_01 |  |  |  | 
 |  | Human |  | CD4/CD8 Human Primary T cell |  | 
 |  | Male |  | 
 |  | nucleofection |  |  |  | 75 pmol Cas9 protein; 3-fold molar excess of sgRNA |  |  |  |  |  |  |  |  |  | ribonucleoprotein (RNP) |  |  |  |  |  | 
 |  
                | Measured Values |  
                | Samples Size: | 3 |  |  |  
                
                
             
                 
                     
                     
                      
                
                | Mean | 94.93  |  
                
                | 1 | 95.2443413042747  |  
                
                | 2 | 94.7736436482417  |  
                
                | 3 | 94.7674723431028  |  |  |  | 
    
    
    
        
            
            
                
                | Publication Title | 
            
            
            
                
                    
                    | CHANGE-seq reveals genetic and epigenetic effects on CRISPR-Cas9 genome-wide activity. NCBI |